24-hour Holter monitoring
DeviceHolter monitor is fitted within 2h of ICU admission to acquire a 24-hour electrocardiogram recording
NCT Number: NCT06044922
Despite advances in post-resuscitation care of patients with cardiac arrest (CA), the majority of survivors who are treated after restoration of spontaneous circulation (ROSC) will have sequelae of hypoxic-ischemic brain injury ranging from mild cognitive impairment to a vegetative state.
Early prognostication in comatose patients after ROSC remains challenging. Recent recommendations suggest carrying out clinical and paraclinical tests during the first 72 h after ROSC, to predict a poor neurological outcome with a specificity greater than 95% (no pupillary and corneal reflexes, bilaterally absent N20 somatosensory evoked potential wave, status myoclonus, highly malignant electroencephalography including suppressed background ± periodic discharges or burst-suppression, neuron-specific enolase (NSE) > 60 µg/L, a diffuse and extensive anoxic injury on brain CT/MRI), but with a low sensitivity due to frequent confounding factors.
The heart rate variability (HRV) is a simple and non-invasive technique for assessing the autonomic nervous system function. In patients with a recent myocardial infarction, reduced HRV is associated with an increased risk for malignant arrhythmias or death. In neurology, reduced HRV is associated with a poor outcome in severe brain injury patients and allows to predict early neurological deterioration and recurrent ischemic stroke after acute ischemic stroke.
A reduced HRV could be a sensitive, specific and early indicator of diffuse anoxic brain injury after CA.
This multicenter prospective cohort study assesses the added value of early HRV (within 24h of ICU admission) for neuroprognostication after cardiac arrest.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Brest University Hospital, Brest, Brittany Region, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Holter monitor is fitted within 2h of ICU admission to acquire a 24-hour electrocardiogram recording
Time frame: At day-28
The CPC (Cerebral Performance Category) score assesses neurological status after cardiac arrest on a scale of 1 to 5 (1 = conscious and normal; 2 = conscious with moderate disability; 3 = conscious with severe disability; 4 = coma or vegetative state; 5 = death).
The CPC score will be dichotomized as follow: good neurological outcome for categories 1 and 2 and poor neurological outcome or death for categories 3, 4 and 5.
The CPC score will be obtained at day-28 from an in-hospital visit if the patient is still hospitalized or by phone call if patient returned home.
Time frame: At day-28
Time frame: At day-28
Time frame: At day-28
Contact information is provided by the study sponsor or research team.
CMC Ambroise Paré
Other
Acronym: HEAVENwARd
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07434726
Cardiac Arrest, Cardiovascular Diseases
Bern, Switzerland
View Trial DetailsNCT06672159
Arrhythmias, Cardiac, Cardiac Arrest
Trondheim, Norway
View Trial DetailsNCT05890716
Arrhythmias, Cardiac, Cardiac Arrest
Groningen, Provincie Groningen, Netherlands
View Trial DetailsNCT07707037
Anxiety Depression, Cardiac Arrest
Philadelphia, Pennsylvania, United States
View Trial Details